Novartis Gets CDSCO Panel nod to study antimalarial drug KLU156 with Coartem Dr. Divya Colin14 Jan 2024 6:00 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Alembic Pharma Gets CDSCO Panel Nod to Study FDC Carbidopa, Levodopa ER Capsule for export purpose only Dr. Divya Colin14 Jan 2024 5:45 PM ISTNew Delhi: The drug major Alembic Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Recombinant L-Asparginase not approved in India, conduct CT to study: CDSCO Panel tells Gennova Biopharmaceutical Dr. Divya Colin14 Jan 2024 5:00 PM ISTNew Delhi: Highlighting that recombinant L-Asparginase is presently not approved in India, the Subject Expert Committee (SEC) functional under the...
CDSCO Panel Approves Novo Nordisk Protocol Amendment Proposal for Concizumab Dr. Divya Colin13 Jan 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
No safety data available, Conduct Phase-III CT: CDSCO Panel Tells Akums on Norethindrone, Estradiol, Relugolix film-coated tablet Dr. Divya Colin12 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Conduct Phase III CT of Triptorelin to treat chronic pain linked to endometriosis: CDSCO Panel Tells Dr Reddy's Lab Dr. Divya Colin11 Jan 2024 6:00 PM ISTNew Delhi: Citing that the pharmaceutical giant Dr. Reddy's Laboratories has not supplied data on the Indian population for the management and relief...
CDSCO Panel grants Wockhardt's Protocol Amendment Proposal For Cefepime Zidebactam Dr. Divya Colin11 Jan 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Conduct Phase III CT: CDSCO Panel Tells Sun Pharma on FDC Relugolix plus Estradiol plus Norethindrone Acetate Tablets Dr. Divya Colin10 Jan 2024 6:00 PM ISTNew Delhi: Citing that there is no safety and efficacy data on Indian population, the Subject Expert Committee (SEC) functional under the Central Drug...
CDSCO Panel grants J&J Protocol Amendment proposal to study anticancer drug Amivantamab and Lazertinib Dr. Divya Colin9 Jan 2024 5:45 PM ISTNew Delhi: Regarding the study of Amivantamab and Lazertinib in combination with platinum-based chemotherapy compared with platinum-based chemotherapy...
Justify Durvalumab dose: CDSCO Panel Tells AstraZeneca on Study of Dato-DXd and Durvalumab Dr. Divya Colin8 Jan 2024 6:00 PM ISTNew Delhi: Reviewing the drug major AstraZeneca's Phase III clinical trial protocol of the anti-cancer drug of Dato-DXd and Durvualumab, the Subject...
Dr Mansukh Mandaviya inaugurates CDSCO Sub Zonal Office, Central Drug Testing Laboratory in Indore Ruchika Sharma8 Jan 2024 5:00 PM ISTNew Delhi: Dr Mansukh Mandaviya, Union Minister of Health and Family Welfare inaugurated the Central Drugs Standard Control Organization (CDSCO)...
Roche Gets CDSCO Panel Nod to Study anti-cancer Drug Giredestrant for Breast Cancer Dr. Divya Colin7 Jan 2024 6:00 PM ISTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
